Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1978 | 1 |
1999 | 1 |
2008 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Non-covalent SARS-CoV-2 M(pro) inhibitors developed from in silico screen hits.
Sci Rep. 2022 Feb 15;12(1):2505. doi: 10.1038/s41598-022-06306-4.
Sci Rep. 2022.
PMID: 35169179
Free PMC article.
M(pro), the main protease of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is essential for the viral life cycle. ...The compounds of the first chemotype denatured M(pro) and were considered not useful for further development. ...
M(pro), the main protease of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is essential for the viral life cycle. …
The A, M, N, and P1 blood group substances in butanol extracts of human erythrocytes.
Lambert RM, Kratzel RJ, Zelenski KR.
Lambert RM, et al.
Immunol Commun. 1978;7(4):461-70. doi: 10.3109/08820137809047629.
Immunol Commun. 1978.
PMID: 669752
Group A substance was recovered in both aqueous phase and butanol phase extracts, M and N substance in aqueous phase extracts only, and P1 substance only in butanol phase extracts. Use of high concentrations of extract resulted in detection of P1 activity in aqueous phase …
Group A substance was recovered in both aqueous phase and butanol phase extracts, M and N substance in aqueous phase extracts only, a …
Item in Clipboard
Decontamination of surgical instruments from prions. II. In vivo findings with a model system for testing the removal of scrapie infectivity from steel surfaces.
Lemmer K, Mielke M, Kratzel C, Joncic M, Oezel M, Pauli G, Beekes M.
Lemmer K, et al.
J Gen Virol. 2008 Jan;89(Pt 1):348-358. doi: 10.1099/vir.0.83396-0.
J Gen Virol. 2008.
PMID: 18089760
In the search for effective, instrument-compatible and routinely applicable decontamination procedures, a previous study [Lemmer, K., Mielke, M., Pauli, G. & Beekes, M. (2004). J Gen Virol 85, 3805-3816] identified promising reagents in an in vitro carrier assay …
In the search for effective, instrument-compatible and routinely applicable decontamination procedures, a previous study [Lemmer, K., Mielke …
Item in Clipboard
Synthesis, development and in vitro evaluation of drug delivery systems with protective effect against degradation by pepsin.
Bernkop-Schnürch A, Kirchmayer R, Kratzel M.
Bernkop-Schnürch A, et al.
J Drug Target. 1999;7(1):55-63. doi: 10.3109/10611869909085492.
J Drug Target. 1999.
PMID: 10614815
The IC50 of this novel inhibitor was determined to be 6.65+/-1.05x10(-6) M. Mediated by a carbodiimide it was covalently bound to polycarbophil and sodium carboxy-methyl cellulose (NaCMC). ...
The IC50 of this novel inhibitor was determined to be 6.65+/-1.05x10(-6) M. Mediated by a carbodiimide it was covalently bound to pol …
Item in Clipboard
Cite
Cite